nandrolone has been researched along with buserelin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y | 1 |
Aso, T; Fukunaga, M; Hagino, H; Harada, T; Momoeda, M; Taketani, Y; Terakawa, N | 1 |
Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K | 1 |
Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C | 1 |
1 review(s) available for nandrolone and buserelin
Article | Year |
---|---|
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People | 2012 |
2 trial(s) available for nandrolone and buserelin
Article | Year |
---|---|
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
Topics: Abdominal Pain; Administration, Intranasal; Administration, Oral; Bone Density; Buserelin; Double-Blind Method; Dyspareunia; Endometriosis; Female; Humans; Japan; Low Back Pain; Nandrolone; Pain; Pain Measurement; Treatment Outcome | 2009 |
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2011 |
1 other study(ies) available for nandrolone and buserelin
Article | Year |
---|---|
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1998 |